Search results
Showing 1006 to 1020 of 1809 results for nice guidelines
Help us improve NICE: take part in research to help us develop better products and services.
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence
NICE has developed a medtech innovation briefing (MIB) on Accuro for guiding epidural or spinal anaesthesia .
focus on what matters most. The NICE prioritisation board will drive this decision making process. The role of the NICE...
Evidence-based recommendations on percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure in adults. This involves putting a small electronic pressure sensor into the pulmonary artery to measure blood pressure.
View recommendations for IPG711Show all sections
can find out more about each type of NICE guidance and how it can be used. Guidelines Our guidelines make...
Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had pemetrexed and cisplatin.
Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) (DG60)
Evidence-based recommendations on digital technologies for assessing attention deficit hyperactivity disorder (ADHD)
Lung volume reduction surgery for advanced emphysema (IPG114)
Evidence-based recommendations on lung volume reduction surgery for treating advanced emphysema. This involves removing damaged lung tissue using a special stapling device, a laser, or both.
View recommendations for IPG114Show all sections
Sections for IPG114
The NGAL Test for early diagnosis of acute kidney injury (MIB3)
NICE has developed a medtech innovation briefing (MIB) on the NGAL Test for early diagnosis of acute kidney injury .
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
NICE has developed a medtech innovation briefing (MIB) on QuickChange Incontinence Wrap for urinary incontinence in men .
Percutaneous transluminal renal sympathetic denervation for resistant hypertension (IPG754)
Evidence-based recommendations on percutaneous transluminal renal sympathetic denervation for resistant hypertension. This involves inserting a device through the skin (percutaneous) into an artery in the thigh and then into the renal arteries (transluminal). It sends radio or sound waves to destroy the nerves in the renal arteries (sympathetic denervation). The aim is to lower blood pressure.
View recommendations for IPG754Show all sections
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation .
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (TA913)
Evidence-based recommendations on mavacamten (Camzyos) for symptomatic obstructive hypertrophic cardiomyopathy.
Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making